Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-Blind, Follow-On Study of Pitavastatin (4 mg) Versus Atorvastatin (20 mg and 40 mg), With a Single-Blind Extension of Treatment, in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia

NCT00344370 is registered in ClinicalTrials.gov with Kowa Research Europe as lead sponsor.

NCT NCT00344370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00344370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-Blind, Follow-On Study of Pitavastatin (4 mg) Versus Atorvastatin (20 mg and 40 mg), With a Single-Blind Extension of Treatment, in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia
Lead sponsor
Kowa Research Europe
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2006
Completion date
April 30, 2008
Enrollment
214 (actual)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

dyslipidemia, type ii diabetes mellitus